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pDifferential Effect of Low-Dose Aspirin for Primary Prevention of
Atherosclerotic Events in Diabetes Management: A Subanalysis of the
JPAD Trial
Okada S, Moriimoto T, Ogaw H, et al. Diabetes Care 2011;34:1277-83.
Conclusion: Low-dose aspirin reduces atherosclerotic events predom-
inately in patients with diabetes treated with diet alone and not in patients
treated with oral hyperglycemic agents or with insulin.
Summary: There have been two large trials investigating low-dose
aspirin and its’ ability to reduce cardiovascular events in patients with
diabetes but without known vascular disease. Both were unable to demon-
strate benefit, but both trials had potential flaws. The Prevention of Progres-
sion of Arterial Disease and Diabetes (POPADAD) trial failed to document
a benefit of aspirin in Scottish patients with either type 1 or type 2 diabetes.
However, there were fewer cardiovascular events than anticipated and low
compliance with aspirin (Belch J. BMJ 2008;337:a1840). The second trial,
Japanese Primary Prevention of Atherosclerosis with Aspirin for Diabetes
(JPAD) trial did demonstrate a 20% reduction in atherosclerotic events with
aspirin but did not reach statistical significance (Ogawa H. JAMA 2008;300:
2134-41). There have also been epidemiologic studies suggesting patients
with diabetes treated with insulin have increased mortality compared to
those receiving oral hypoglycemic agents (OHAs)or managed by diet (
Muggeo M, et al. Diabetologia 1995;38:318-25). It follows patients with
diabetes treated with insulin may be the most likely to benefit from low-dose
aspirin therapy. The authors therefore performed a subanalysis of the JPAD
trial. Their working hypothesis was low-dose aspirin would be beneficial for
primary prevention in patients with diabetes receiving insulin. JPAD was a
randomized, controlled, open label trial. In the trial, 2539 patients with type
2 diabetes and no previous cardiovascular disease were randomly assigned to
low-dose aspirin (81 or 100 mg daily) or to no aspirin. Median follow-up
was 4.4 years. This paper analyzes the differential affects of low-dose aspirin
in preventing atherosclerotic events in groups receiving different types of
diabetic management. At baseline there 326 patients treated with insulin,
1750 treated with OHAs and 463 managed with diet alone. Patients treated
with insulin had the worst glycemic control and the longest history of
diabetes and the highest prevalence of diabetic microangiopathy. Patients
treated with diet alone had the opposite characteristics. Atherosclerotic
events occurred at an incidence of 26.6, 14.6 and 10.4 cases per 1000 person
years respectively in the insulin, OHA, and diet alone groups. In patients
treated with insulin or OHAs, low-dose aspirin did not affect atherosclerotic
events (insulin HR 1.19; 95%CI, 0.6-2.4; and OHA HR, 0.84; 95% CI,
0.57-1.24). In the diet-alone group, however, low-dose aspirin did reduce
atherosclerotic events despite the lowest event rate (HR, 0.21; 95% CI
0.05-0.64).
Comment: The fact aspirin was not effective in preventing atheroscle-
rotic events in patients with diabetes treated with insulin or OHAs is
compatible with recent literature. However, the finding that aspirin was
effective in reducing vascular events in patients treated with diet alone is a
new and a bit surprising. Perhaps in patients with advanced diabetes the
burden of atherosclerosis is such new events are unpreventable by aspirin, or
such patients have some degree of aspirin resistance. The decision to use
aspirin to prevent vascular events in patients with diabetes should consider
not only conventional cardiovascular risk factors, but the stage of the
diabetes as well.
Adapted from Moneta G et al. 2012 Year Book of Vascular Surgery.
Philadelphia, PA: Elsevier; 2012; with permission.
Longevity and Outcomes of Axillary Valve Transplantation for Severe
Lower Extremity Chronic Venous Insufficiency
Kabbani L, Escobar GA, Mansour F, et al. Ann Vasc Surg 2011;25:496-501.
Conclusion: Venous valve transplantation has good initial technical
and symptomatic success but poor long term valve competency and symp-
tom control.
Summary: Venous valve reconstruction using venous valve transplan-
tation with a segment of axillary vein can be used to treat a small subset of
patients with chronic venous insufficiency (CVI) who fail conservative
therapy or more standard techniques of superficial venous surgery. In this
study the authors report their experience with upper extremity to lower
extremity venous valve transplantation for treatment of refractory CVI.
There were 139 complex venous valve reconstructions performed between
1991 and 2007 for CVI, 18 underwent upper extremity to lower extremity
venous valve transplantation. In 13 cases an upper extremity valve was
transplanted to the popliteal vein, to the common femoral vein in 6 cases and
to the saphenofemoral junction in two cases for a total of 21 procedures. All ratients had follow-up with duplex scanning to assess valve competency and
eceived clinical follow-up as well. Mean follow-up was 37 months and 57%
f the patients were men with a mean age of 44 years. Clinically, 57% of the
imbs were CEAP 5-6. The mean preoperative venous disability score was
.95. 66% of the patients had postthrombotic valvular dysfunction and no
roximal venous obstruction was documented in any patient at the time of
alve transplantation. Technical success of the operation was defined as a
ompetent valve at the end of the procedure and was achieved in 20 of 21
ases. Post operative complications, primarily bleeding, occurred in one-
hird of patients. The mean postoperative venous disability score was 2.65
nd this increased to 2.75 (P  ns compared with baseline) at the last
ostoperative visit. Median time to return of symptoms was 12 months and
edian reflux free survival was 15 months.
Comment: Axillary valve transplantation is an example of a theoreti-
ally sound but poorly performing procedure to treat deep venous insuffi-
iency in patients with CVI. The operation is not easy. Some axillary valves
re incompetent. In six of the author’s patients the valves needed to be
epaired at the primary operation to achieve competency. Nearly 75% of the
atients in this series were postthrombotic patients, arguably the most
ifficult subset of patients with refractory CVI. Whereas it appears axillary
alve transplantation does not work well for postthrombotic CVI, there may
e some subsets of patients, ie those with primary deep venous insufficiency,
ho may still potentially benefit from the procedure.
Adapted from Moneta G et al. 2012 Year Book of Vascular Surgery.
hiladelphia, PA: Elsevier; 2012; with permission.
ajor Arterial Aneurysms and Pseudoaneurysms in Behcet’s Disease:
esults from a Single Centre
ho SB, Kim T, Cho, S, et al. Scandinavian Rheumatology 2011;40:64-7.
Conclusion: One-third of patients with Behcet’s disease (BD) and
ith BD related aneurysms will, upon further investigation, be found to have
dditional aneurysms.
Summary: BD is an autoinflammatory, multisystem, vasculitis that
ffects all sizes and types of vessels (Cocco G, et al. Open Cardiovasc Med J
010;4:63-70). BD, however, mostly affects veins, venules and capillaries
Alpagut U, et al. Ann Vasc Surg 2007;21:232-9). Major arterial involve-
ent is infrequent and occurs in only about 1 to 7% of BD patients. Arterial
athology is both arterial occlusions and aneurysm rupture, and it is the
rterial involvement that correlates closely with mortality and morbidity in
D patients. This report focuses on 30 BD patients from Korea diagnosed
ith aneurysms and pseudoaneurysms of major arteries. The focus was on
nitial clinical symptoms, location of aneurysm lesions, and treatment re-
ponses. The data were derived from medical records retrospectively. There
ere 47 aneurysms and pseudoaneurysms in the 30 patients (32 saccular
neurysms, eight fusiform aneurysms, and seven pseudoaneurysms. Most
seudoaneurysms and aneurysms (27 patients, 90%) had not ruptured. Most
atients presented with symptoms (70 %, n 21). One-third of patients had
wo or more aneurysm lesions. Aneurysm recurrence was observed in five
atients after treatment with a stent graft (n 3) graft interposition (n 1)
r embolization (n  1).
Comment: Large artery arteritis is an infrequent, but a major cause of
ortality in BD patients. The article confirms the clinical impression of an
pparent high rate of graft related complications with treatment of BD
neurysms; perhaps related to ongoing inflammation in the BD patient. Of
ost interest is the fact that if you find an aneurysm in a patient with BD, if
ou look further, one-third of the time you will find an additional aneurysm.
herefore patients with BD and a discovered aneurysm essentially require
isualization of their entire arterial system. BD arterial aneurysms can be
ound in virtually any artery from the aortic arch to the pulmonary circula-
ion, as well as in intracranial arteries and the tibial arteries.
Adapted from Moneta G et al. 2012 Year Book of Vascular Surgery.
hiladelphia, PA: Elsevier; 2012; with permission.
ptimizing Protocols for Risk Prediction Asymptomatic Carotid Ste-
osis Using Embolic Signal Detection: The Asymptomatic Carotid
mboli Study
ing A, Shipley M, Marksu H, et al. Stroke 2011;42:2819-24.
Conclusion: Transcranial Doppler (TCD) recordings comprising 2
aseline sessions lasting one hour provide the best prediction of stroke risk in
atients with asymptomatic carotid stenosis.Summary: Randomized clinical trials have demonstrated that stroke
isk can be reduced with prophylactic carotid endarterectomy (CEA). How-
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April 20121220 Abstractsever, benefit is small and it has been calculated that to prevent one disabling
stroke over a 5-year period, approximately 32 CEAs need to be performed.
Current estimates are that with best medical treatment, stroke risk can be
reduced from approximately 2% per year, found in the randomized trials of
CEA for asymptomatic disease, to  1% per year with current best medical
management (Abbott AL. Stroke 2009;40:e573-e583; and Marquardt L.
Stroke 2010;41:e11-e17). The Asymptomatic Carotid Emboli Study
(ACES) found embolic signals detected with TCD on baseline recordings of
1 hour predicted stroke risk over a 2-year follow-up time (Markus HS.
Lancet Neurol 2010;9:663-71). The current study acknowledges embolic
signal detection is time consuming and sought to determine if similar
predictive information could be attained from simpler recording protocols.
This was a predefined secondary analysis of the ACES. The authors evaluated
temporal variation of embolic signals and attempted to determine predictive
yield associated with different recording protocols and/or a higher thresh-
old level of embolic signals to indicate increased risk ( two embolic
signals). Different recording protocols were compared using sensitivity and
specificity analysis from receiver operator characteristic curves. There were
477 patients in this study with asymptomatic carotid stenosis, 467 had
baseline TCD recordings adequate for analysis. Of these, 77 had embolic
signals on one or both of two 1-hour baseline recordings. Embolic signal
status on two recordings was significantly associated (P .0001). There was,
however, poor agreement between embolic signal positivity on the two
recordings (k  0.266). For the primary outcome of ipsilateral stroke or
transient ischemic attack, two baseline recordings lasting 1 hour had greater
predictive accuracy than either the first baseline recording alone (P 
.0005), a single 30-minute recording (P .0001), or two recordings lasting
30 minutes (P  .0001). For the outcome of ipsilateral stroke 2 recordings
lasting 1 hour had greater predictive accuracy when compared to all other
recording protocols (all P  .0001).
Comment: The elephant in the room is that if one decides to use TCD
embolic signal detection to predict stroke in patients with asymptomatic
carotid disease, application of the technique will be labor- and time-intensive
for vascular laboratories. It will also require experienced operators and
validation of commercially available embolic signal detection symptoms.
Given the low therapeutic index for CEA for patients with asymptomatic
stenosis, the time, effort, and cost may be worth it. However, it is unlikely
anyone is willing going to pay for this in the foreseeable future.
Adapted from Moneta G et al. 2012 Year Book of Vascular Surgery.
Philadelphia, PA: Elsevier; 2012; with permission.
Patients With Severe Asymptomatic Carotid Artery Stenosis Do Not
Have a Higher Risk of Stroke and Mortality After Coronary Artery
Bypass Surgery
Mahmoudi M, Hill PC, Xue Z, et al. Stroke 2011;42:2801-5.
Conclusion: Severe carotid artery stenosis is not a risk factor for
mortality or stroke in patients undergoing coronary artery bypass grafting
(CABG).
Summary: Strokes complicate CABG approximately 2% of the time
(Naylor AR, et. al. Eur J Vas Endovasc Surg. 2002; 23:283-294) and most
strokes complicating CABG occur within 24 hours of operation with mor-
tality rates of up to 25%. There is, therefore, controversy as to the preferred
management of patients undergoing CABG who have severe carotid artery
stenosis.
The authors performed a retrospective study of 778 patients with
carotid duplex ultrasound who underwent an isolated CABG procedure in
their institution from January 2003 to December 2009. There were 117
patients with severe carotid artery stenosis, defined as 75 % stenosis.
Patients with severe carotid artery stenosis were then compared to those
without severe carotid artery stenosis (n  761). Data were analyzed for
rates of stroke and mortality during hospitalization for CABG. 30 day
mortality was also recorded. Patients with severe carotid artery stenosis had
a higher prevalence of peripheral arterial disease, heart failure, and were
older. However, patients with severe carotid artery stenosis had similar rates
of in-hospital stroke (3.4% vs 3.6%; P  1.0) and mortality (3.4% vs 4.2%;
P  1.0) compared to patients without severe carotid artery stenosis. The
two groups also had similar 30-day mortality rates (3.4% for those with
severe carotid artery stenosis vs 2.9% for those without severe carotid artery
stenosis; P  .51).
Comment: Severe carotid artery stenosis was not associated with an
increased risk of in-hospital stroke, in-hospital mortality, or 30-day mortality
in this study following CABG. Ricotta et. al. determined the major morbid-
ity of combining carotid endarterectomy (CEA) with CABG relates to
patient comorbidities rather than the CEA (Ricotta JJ, et al. J Vasc Surg
2005;41:397-401). Others have found, however, similar to this study,
severe carotid artery stenosis does not significantly contribute to neurologic
complication rates following CABG. It would seem the preponderance of
the data would suggest CEA to increase safety of CABG is an ineffective, or
a t best a marginally effective, strategy. The decision to perform CEA is
probably best made on individual patient circumstances irrespective of the
need for coronary surgery.
p
cAdapted from Moneta G et al. 2012 Year Book of Vascular Surgery.
hiladelphia, PA: Elsevier; 2012; with permission.
ranscranial Doppler Ultrasounography for Diagnosis of Cerebral
asospasm After Aneurysmal Subarachnoid Hemorrhage: Mean Blood
low Velocity Ratio of the Ipsilateral and Contralateral Middle Cere-
ral Arteries
akae R, Yokota H, Yoshida D, et al. Neurosurgery 2011;69:876-82.
Conclusion:The ratio of the ipsilateral to contralateral middle cerebral
rtery (MCA) mean blood flow velocity has better correlation with clinical
eaningful consequences of cerebral vasospasm than absolute mean velocity
n the MCA.
Summary: Transcranial Doppler (TCD) is one of the areas of nonin-
asive testing subject to accreditation by the Intersocietal Commission for
ccreditation of Vascular Laboratories (ICAVL). Establishment of diagnos-
ic criteria for clinically meaningful end points is important in the accredita-
ion process. TCD is most frequently used to monitor for cerebral vaso-
pasm. Diagnostic criteria for cerebral vasospasm focus on absolute mean
elocities in the MCA or comparing of mean velocities in the ipsilateral MCA
ersus the ipsilateral extracranial internal carotid artery (ICA); the so called
indegaard ratio. A recent meta-analysis concluded TCD of the MCA has a
igh specificity (99%), a high positive predictive value (97%), but a low
ensitivity in detecting MCA vasospasm (Lysakowski C. Stroke 2001;32:
292-8). In an effort to improve sensitivity of TCD parameters in detecting
erebral vasospasm, the authors reviewed their patients with subarachnoid
emorrhage admitted to their institution from July 2003 to August 2009.
hey sought to determine the TCD parameter that was best associated with
elayed cerebral ischemia defined as a neurologic deficit or CT evidence of
erebral infarction secondary to vasospasm. They used both ipsilateral and
ontralateral MCA mean blood flow velocities with the ipsilateral mean flow
elocity defined as the side with the highest mean flow velocity and the
ontralateral side defined as the MCA with the lowest mean flow velocity.
eceiver operator characteristic (ROC) analysis was used to determine the
CD parameter best associated with delayed cerebral ischemia. There were
42 patients retrospectively analyzed with 1262 TCD studies. ROC curve
nalysis showed the overall predictive value for delayed cerebral infarction
ad an area under the curve of 0.86 (95% CI, 0.76-0.96) when the ipsilateral
ean blood flow velocity of the MCA was compared to the mean flow
elocity of the contralateral MCA. The area under the curve was 0.80 (0.71-
.88) when the absolute mean MCA flow velocity was used. Discrimination
etween patients with and without delayed cerebral infarction was best with
n ipsilateral to contralateral (I/C) mean blood flow velocity ratio of 1.5.
Comment: In this study, TCD had a higher sensitivity (77%) and
pecificity (80%) for detecting delayed cerebral ischemia when the I/C ratio
f mean blood flow velocities in the MCA was used. This ratio was more
losely related to clinically significant vasospasm than absolute mean blood
ow velocities. It would have been interesting if the authors had also
ompared the proposed I/C MCA mean blood flow velocity ratio with the
ore commonly employed Lindegaard ratio. Confirmation of vasospasm
ith angiography would also have contributed positively to the robustness
f the data. Nevertheless, the paper is valuable in purposing a new TCD
arameter that may have increased sensitivity in detection of cerebral vaso-
pasm.
Adapted from Moneta G et al. 2012 Year Book of Vascular Surgery.
hiladelphia, PA: Elsevier; 2012; with permission.
ype-Selective Benefits of Medications in Treatment of Acute Aortic
issection (from the International Registry of Acute Aortic Dissection
IRAD])
uzuki T, Isselbacher EM, Nienaber CA, et al. Am J Cardiol 2012;109:
22-7.
Conclusion: Beta blockers are associated with improved outcomes in
ll types of aortic dissection patients, including those managed operatively
nd nonoperatively. Calcium channel blockers are associated with improved
urvival overall in patients with type B dissection and those managed
onoperatively. Angiotensin converting enzyme inhibitors do not have an
ssociation with mortality.
Summary:Medical management of aortic dissection depends primarily
n opinion and historic observational studies (Hiratzka LF. Circulation
010;121:e266-e369). Beta blockers are generally regarded as first-line
edications and calcium channel blockers are also frequently employed.
ecent studies have also suggested benefit with inhibitors of the renin
ngiotensin system (Swada TE. Eur Heart J 2009;30:2461-9). The lack of
olid evidence of which drugs to employ for medical management of aortic
issection has led to disparate guidelines from various societies.
The authors analyzed data from the International Registry of Acute
ortic Dissection (IRAD) to try and better understand current approaches
o medical management and the effects of medications on outcomes in
atients with aortic dissection. IRAD is a multinational registry of 24 referral
enters in 12 countries. The authors used data from all patients with aortic
